MarketPulse

Moderna

3 articles
BenzingaBenzinga··Vandana Singh

Moderna Shares Slide Despite Revenue Beat, Weighed by $2.22B Legal Settlement

Moderna beats revenue estimates with $389M vs. $227.97M consensus but shares fall 2.05% due to $2.22 per share litigation settlement charge.
PFEMRNABNTX2026 guidancebiotech
The Motley FoolThe Motley Fool··Adria Cimino

Moderna's 70% Rally Fuels Debate: Growth Story or Overheated Biotech?

Moderna stock surges 70% in 2026 on vaccine and cancer therapy pipeline expansion, but $2.8B losses amid $1.9B revenue temper bullish sentiment.
MRNAbiotechoncology
The Motley FoolThe Motley Fool··Adria Cimino

Coatue Management Exits CoreWeave While Establishing Moderna Position

Coatue Management exited CoreWeave with 80% gains, reallocating capital toward a new Moderna position ahead of the biotech stock's 50% rally.
CRWVTSMMRNAportfolio rebalancing13F filings